Puma Biotechnology Inc reports results for the quarter ended in June - Earnings Summary

Puma Biotechnology

03/08/2023 22:55

* Puma Biotechnology Inc  PBYI.OQ  reported quarterly
adjusted
earnings of 5 cents​​ per share for the quarter ended in June.
The mean expectation of four analysts for the quarter was
for earnings of one cent per share.
    * Revenue fell 8.3% to $54.60 million from a year ago;
analysts
expected $51.73 million. 
    * Puma Biotechnology Inc's reported EPS for the quarter was
5
cents​.
    * The mean earnings estimate of analysts had fallen by
about 91.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Puma Biotechnology Inc shares had risen by 2.3% this
quarter and
lost 14.7% so far this year.
    * The company reported quarterly net income of $2.1 million.
    * Wall Street's median 12-month price target for Puma
Biotechnology Inc is $4.50 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and 2 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 3 at 09:55 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      0.01           0.05           Beat
 Mar. 31 2023      -0.07          0.03           Beat
 Dec. 31 2022      0.05           -0.12          Missed
 Sep. 30 2022      -0.05          -0.01          Beat